Republic of Korea vs South Sudan: Drug use disorder deaths
Republic of Korea
44.39 deaths
in 2021
South Sudan
39.8 deaths
in 2021
Republic of Korea rank
79th
South Sudan rank
81st
Drug use disorder deaths over time
- Republic of Korea
- South Sudan
How they compare
Republic of Korea currently reports 44.39 deaths against 39.8 deaths in South Sudan, a difference of 4.59 deaths.
That makes Republic of Korea's figure about 1.1 times South Sudan's.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Republic of Korea ahead.
Republic of Korea ranks 79th and South Sudan ranks 81st of 194 countries.
Across the 3 decades both report, Republic of Korea averaged higher in 1 and South Sudan in 2.
Head to head by decade
| Decade | Republic of Korea | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.51 deaths | 20.75 deaths | 0.245 deaths | South Sudan |
| 2010s | 24.87 deaths | 37.66 deaths | 12.79 deaths | South Sudan |
| 2020s | 40.84 deaths | 37.27 deaths | 3.57 deaths | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths, Republic of Korea or South Sudan?
- Republic of Korea, at 44.39 deaths against 39.8 deaths in South Sudan as of 2021.
- What is the difference in drug use disorder deaths between Republic of Korea and South Sudan?
- 4.59 deaths, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and South Sudan?
- 22 years are reported by both, from 2000 to 2021.
- How do Republic of Korea and South Sudan rank globally for drug use disorder deaths?
- Republic of Korea ranks 79th and South Sudan ranks 81st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from opioid use disorders in both sexes.